{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"Answers from the Lab","title":"Test helps identify elusive central nervous system pathogens: Robin Patel, M.D.","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/04d89edb\"></iframe>","width":"100%","height":180,"duration":430,"description":"Robin Patel, M.D., explains how a new Mayo Clinic Laboratories' assay can identify central nervous system pathogens that standard tests fail to detect. Rapid, precise diagnosis is essential to preventing long-term effects from these infections.Show notesSpeaker 3: (00:32) Please give us a brief introduction of yourself and your role at Mayo Clinic. Speaker 3: (01:44) Could you please expand a bit on this newly developed sequencing assay — which is a shotgun metagenomic test on CSF — and explain how it's different from other sequencing methods? Speaker 3: (02:43) Could you tell us more about the specific group of patients this test would be used for and how a provider might identify those patients? When during the care process should this be ordered? Speaker 3: (04:12) Could you talk about the alternative test options and how they compare? Speaker 3: (05:42) How are the results used in patient care?","thumbnail_url":"https://img.transistorcdn.com/jhRCftFebxnTMwoIbA_WoqrSKwFRD_Y2kbh0JDjhx14/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9lYjNj/ZDc0NTE0MWNlOWRl/YzRiN2Q3NDg2Mjg5/YWE4MS5qcGc.webp","thumbnail_width":300,"thumbnail_height":300}